Brief: Aptahem enters production agreement with Biospring
10/08/2017 12:32
Aug 10 (Reuters) - APTAHEM AB APTA.ST
* APTAHEM ENTERS PRODUCTION AGREEMENT WITH BIOSPRING
* BIOSPRING HAS BEEN CONTRACTED FOR SUBSTANCE PRODUCTION OF
DRUG CANDIDATE APTA-1
Source text for Eikon: ID:nWkrpvWCl
Further company coverage: APTA.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Aptahem AB
See all newsBrief: Aptahem Signs Non Binding Term Sheet For Development, Manufacturing And Distribution Of Apta-1 For Sepsis In Europe
Brief: Aptahem Receives Patent Approval In India For Patent Family 1
Brief: Aptahem Rights Issue Oversubscribed
Brief: Aptahem Enters Agreement With Granzer Regulatory Consulting
Brief: Aptahem Largest Shareholder Suggests Dr Bert Junno New Chairman